MyAverix Finance
SHG · Healthcare
NanJing Pharmaceutical Co Ltd (600713)
Drug Manufacturers - General
NanJing Pharmaceutical Co Ltd (600713) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-28, reported market cap is $6.66B, P/E ratio is 13.39, net margin is 1.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600713
NanJing Pharmaceutical Co Ltd (600713) — FAQ
What is NanJing Pharmaceutical Co Ltd's market cap?
NanJing Pharmaceutical Co Ltd (600713) has a reported market cap of $6.66B (data as of 2026-03-28).
What is 600713's P/E ratio?
The price-to-earnings (P/E) ratio for NanJing Pharmaceutical Co Ltd (600713) is 13.39 (data as of 2026-03-28).
Does NanJing Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for NanJing Pharmaceutical Co Ltd (600713). Check the MyAverix Finance app for the latest dividend data.
What sector is NanJing Pharmaceutical Co Ltd in?
NanJing Pharmaceutical Co Ltd (600713) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is 600713 listed on?
600713 is listed on SHG.
What is NanJing Pharmaceutical Co Ltd's net margin?
NanJing Pharmaceutical Co Ltd (600713) reports a net margin of 1.0% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.